Gabapentin and Chronic Post Surgical Pain
Withdrawn before enrolling · Phase 3 · Has a placebo group
Conditions studied: Pain, Postoperative, Scoliosis Idiopathic
In brief
The purpose of this study is to investigate the effect of a common pain medication (gabapentin) on chronic postsurgical pain in pediatric patients who require surgery for idiopathic scoliosis.
Key facts
- Study ID
- NCT03867240
- Run by
- Emory University
- People needed
- 0
- Starts
- 2019-06-01
- Expected to finish
- 2022-09-01
- Last updated by the study team
- 2021-02-08
Who can join
Age: 10 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Be aged 10-18 years at the time of surgery
- Have a diagnosis of idiopathic scoliosis and/or kyphosis
- Be undergoing elective posterior spinal fusion
- Have only mild systemic disease
You may not qualify if…
- A diagnosis of neuromuscular scoliosis and/or kyphosis
- A diagnosis of chronic pain
- Used opioids in the past 6 months
- Developmental delay
- Liver or kidney disease
- Obstructive sleep apnea
- Body mass index >40
- Be pregnant or breastfeeding
Where it is running
- Children's Healthcare of Atlanta — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.